The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Hanna Rosenmann

The Department of Neurology

Agnes Ginges Center for Human Neurogenetics

Hadassah Hebrew University Medical Center

Ein Karem

Israel

[email]@hadassah.org.il

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • The Department of Neurology, Agnes Ginges Center for Human Neurogenetics, Hadassah Hebrew University Medical Center, Ein Karem, Israel. 2003 - 2011
  • Department of Neurology, Hadassah University Hospital, Ein Karem, Jerusalem 91120, Israel. 2003

References

  1. CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease. Rosenmann, H. J. Mol. Neurosci. (2011) [Pubmed]
  2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann, H., Grigoriadis, N., Eldar-Levy, H., Avital, A., Rozenstein, L., Touloumi, O., Behar, L., Ben-Hur, T., Avraham, Y., Berry, E., Segal, M., Ginzburg, I., Abramsky, O. Exp. Neurol. (2008) [Pubmed]
  3. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Rosenmann, H., Grigoriadis, N., Karussis, D., Boimel, M., Touloumi, O., Ovadia, H., Abramsky, O. Arch. Neurol. (2006) [Pubmed]
  4. Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects. Rosenmann, H., Meiner, Z., Geylis, V., Abramsky, O., Steinitz, M. Neurosci. Lett. (2006) [Pubmed]
  5. The Fas promoter polymorphism at position -670 is not associated with late-onset sporadic Alzheimer's disease. Rosenmann, H., Meiner, Z., Kahana, E., Aladjem, Z., Friedman, G., Ben-Yehuda, A., Grenader, T., Wertman, E., Abramsky, O. Dement. Geriatr. Cogn. Disord (2004) [Pubmed]
  6. Lack of association of interleukin-1beta polymorphism with Alzheimer's disease in the Jewish population. Rosenmann, H., Meiner, Z., Dresner-Pollak, R., Kahana, E., Aladjem, Z., Grenader, T., Wertman, E., Abramsky, O. Neurosci. Lett. (2004) [Pubmed]
  7. An association study of a polymorphism in the heparan sulfate proteoglycan gene (perlecan, HSPG2) and Alzheimer's disease. Rosenmann, H., Meiner, Z., Kahana, E., Aladjem, Z., Friedman, G., Ben-Yehuda, A., Grenader, T., Wertman, E., Abramsky, O. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2004) [Pubmed]
  8. A polymorphism in the complement component C1r is not associated with sporadic Alzheimer's disease. Rosenmann, H., Meiner, Z., Kahana, E., Aladjem, Z., Friedman, G., Ben-Yehuda, A., Grenader, T., Wertman, E., Abramsky, O. Neurosci. Lett. (2003) [Pubmed]
  9. An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer's disease. Rosenmann, H., Meiner, Z., Kahana, E., Aladjem, Z., Friedman, G., Ben-Yehuda, A., Grenader, T., Wertman, E., Abramsky, O. Neurosci. Lett. (2003) [Pubmed]
 
WikiGenes - Universities